Anthraquinones as a new class of antiviral agents against human immunodeficiency virus

Antiviral Res. 1990 May;13(5):265-72. doi: 10.1016/0166-3542(90)90071-e.

Abstract

Various anthraquinones substituted with hydroxyl, amino, halogen, carboxylic acid, substituted aromatic group, and sulfonate were tested to determine their activity against human immunodeficiency virus type 1 (HIV-1) in primary human lymphocytes. Among the compounds tested, polyphenolic and/or polysulfonate substituted anthraquinones were found to possess the most potent antiviral activity. Hypericin, an anthraquinone dimer previously shown to have activity against nonhuman retroviruses also exhibited anti-HIV-1 activity in lymphocytes. the active anthraquinones inhibited HIV-1 reverse transcriptase. However, this enzyme inhibition was selective only for 1,2,5,8-tetrahydroanthraquinone and hypericin. Hypericin interacts nonspecifically with protein suggesting that this effect may dictate its inhibitory activity against the viral reverse transcriptase.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acquired Immunodeficiency Syndrome / drug therapy*
  • Anthraquinones / pharmacology*
  • Antiviral Agents / pharmacology*
  • HIV-1 / drug effects*
  • HIV-1 / enzymology
  • HIV-1 / growth & development
  • Humans
  • Lymphocytes / microbiology
  • RNA-Directed DNA Polymerase / metabolism
  • Virus Replication / drug effects

Substances

  • Anthraquinones
  • Antiviral Agents
  • RNA-Directed DNA Polymerase